PHD Discussions Logo

Ask, Learn and Accelerate in your PhD Research

Question Icon Post Your Answer

Question Icon

What specific pre-administration assessments and post-administration monitoring precautions are absolutely necessary when considering atropine for an older adult?

I'm writing a hospital protocol for managing symptomatic bradycardia in the elderly. The section on atropine needs to be explicit and actionable. What vital signs and labs do I check before giving it? How do I screen for contraindications beyond glaucoma? What is the specific monitoring schedule (ECG, mental status, bowel sounds) for the first few hours after administration? Are there specific "stop" criteria (e.g., new-onset confusion) that should trigger discontinuation and reconsideration of therapy?

All Answers (1 Answers In All)

By Vamsi Answered 1 year ago

A strict protocol is essential. Pre-Administration: 1) Medication Reconciliation: Calculate the Anticholinergic Cognitive Burden (ACB) score; an ACB ≥3 is a major risk factor. 2) Contraindications: Documented closed-angle glaucoma, myasthenia gravis, obstructive GI/GU disease (e.g., paralytic ileus, BPH), and severe ulcerative colitis. 3) Baseline Assessment: Record mental status (use a scale like MoCA or CAM), bowel sounds, urinary output, and intraocular pressure if history suggests risk. Administration: Use lower initial dose (0.5 mg IV max initially), administer slowly. Post-Administration Monitoring: For 2-4 hours, monitor: Continuous ECG (for paradoxical bradycardia or tachycardia), mental status every 30 minutes, bowel sounds and subjective GI discomfort. Stop Criteria: Immediate discontinuation and physostigmine consideration upon new delirium, agitation, ileus, or urinary retention. Document the indication clearly; often, transcutaneous pacing is a safer first-line alternative in the frail elderly.

Your Answer